EGFR and non-small cell lung carcinoma: Therefore, the purpose of this study was to investigate the potential effect of common EGFR gene polymorphisms on clinical outcomes in a relatively large group of 436 patients with unresectable NSCLC receiving RT or platinum-based chemoradiotherapy (CHTRT).